Lung cancer
Conditions
Interventions
experimental group 1:novel airway stent implantation (plan 1)
control group:Ultraflex stent implantation
experimental group 2:novel airway stent implantation (plan 1)
experimental group 3:novel airway stent implantation (plan 3)
experimental group 4:novel airway stent implantation (plan 4)
experimental group 5:novel airway stent implantation (plan 5)
Sponsors
Shanghai Pulmonary Hospital Affiliated to Tongji University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) The subjects should be Chinese citizens aged 18 to 60 years old; 2) At screening and baseline follow-up, the subjects must be cby pathologically-onfirmed as lung cancer with malignant airway stenosis; 3) The subjects were in good health and had no clinically significant diseases that may interfere with the trial schedule or operation or affecte the safety of the subjects; 4) The patients should be able to comply with the medication and follow-up schedule.
Exclusion criteria
Exclusion criteria: 1) Subjects with severe upper respiratory tract infection; 2) Subjects with any clinical abnormalities in vital signs at screening or follow-up; 3) Subjects with severe cardiovascular, pulmonary, renal, liver, metabolic, hematological or neurologic diseases, or impaired immune system; 4) Subjects whose airway had been treated with other drugs; 5) Subjects with other reasons that researchers believe they should not be included in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| OS;Luminal diameter; | — |
Countries
China
Contacts
Public ContactLei Zhang
Shanghai Pulmonary Hospital
Outcome results
None listed